Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

Fig. 3

Kaplan–Meier survival estimates after renal transplantation in recipients of kidneys with or without UC-MSCs. a Graft survival in the MSC group was comparable to that in the non-MSC group (P = 0.97). b A similar analysis revealed no significant difference in recipient survival between the two groups (P = 0.15)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us